← All news

TürkiyeResearch and clinical trials

Long-term outcomes of 50 patients with propionic acidemia from Hacettepe

Peer-reviewed publication

A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.

Hacettepe University studied 50 patients diagnosed between 1984 and 2020. The median age at diagnosis was 18 days. Consanguineous marriage was present in 91% of the patients' families. Developmental delay or intellectual disability was seen in 23 patients. During follow-up, 23 patients died, and 27 are alive.

What does it mean for patients and families?

The disease can still follow a severe course today. Heart and brain check-ups should be regular. The treatment plan is made with a metabolic disease doctor.

Source

PubMed (Journal of Pediatric Endocrinology and Metabolism): Clinical and laboratory characteristics of propionic acidemia in a Turkish cohort.

Scientific paper: Clinical and laboratory characteristics of propionic acidemia in a Turkish cohort. Journal of Pediatric Endocrinology & Metabolism, 2025. DOI: 10.1515/jpem-2024-0366 · PubMed 39953904

The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).

This page is translated from the Turkish original.

This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.